EN
首页 资讯 期刊 导师 问答 求职 发Paper 文献直达 高级搜索 期刊列表
当前位置： X-MOL 学术 › Respir. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
Respiratory Research ( IF 4.7 ) Pub Date : 2021-08-09 , DOI: 10.1186/s12931-021-01803-y
Shigeo Muro 1 , Hisatoshi Sugiura 2 , Patrick Darken 3 , Paul Dorinsky 4
Affiliation  

The original version of this article unfortunately contained a mistake [1]. The minor correction of Table 1 was missing. That is, the text ‘FF’ should be ‘GFF’.

The correct Table 1 is given in this erratum.

Table 1 Demographic and baseline disease characteristics (mITT population)
Full size table
  1. 1.

    Muro S, Sugiura H, Darken P, Dorinsky P. Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts. Respir Res. 2021;22:187. https://doi.org/10.1186/s12931-021-01773-1.

    CAS Article PubMed PubMed Central Google Scholar

Download references

Affiliations

  1. Department of Respiratory Medicine, Nara Medical University Graduate School of Medicine, 840 Shijo-cho, Kashihara-shi, 634-8521, Nara, Japan

    Shigeo Muro

  2. Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan

    Hisatoshi Sugiura

  3. AstraZeneca, Wilmington, DE, USA

    Patrick Darken

  4. AstraZeneca, Durham, NC, USA

    Paul Dorinsky

Authors
  1. Shigeo MuroView author publications

    You can also search for this author in PubMed Google Scholar

  2. Hisatoshi SugiuraView author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrick DarkenView author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul DorinskyView author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shigeo Muro.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

Verify currency and authenticity via CrossMark

Cite this article

Muro, S., Sugiura, H., Darken, P. et al. Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts. Respir Res 22, 223 (2021). https://doi.org/10.1186/s12931-021-01803-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12931-021-01803-y

中文翻译：
更正：布地奈德/格隆溴铵/福莫特罗计量吸入器在 COPD 患者中的疗效：来自 KRONOS 研究的事后分析，排除气道可逆性和高嗜酸性粒细胞计数的患者

不幸的是，这篇文章的原始版本包含一个错误 [1]。缺少表 1 的小修正。也就是说，文本“FF”应该是“GFF”。

本勘误表中给出了正确的表 1。

表 1 人口统计学和基线疾病特征（mITT 人群）
全尺寸表
  1. 1.

    Muro S、Sugiura H、Darken P、Dorinsky P. 布地奈德/格隆溴铵/福莫特罗计量吸入器对 COPD 患者的疗效：来自 KRONOS 研究的事后分析，排除了气道可逆性和嗜酸性粒细胞计数高的患者。呼吸系统。2021；22:187。https://doi.org/10.1186/s12931-021-01773-1。

    CAS 文章 PubMed PubMed Central Google Scholar

下载参考

隶属关系

  1. 日本奈良市柏原市四条町 840 奈良医科大学研究生院呼吸内科 634-8521

    室郎茂夫

  2. 日本仙台东北大学医学研究生院呼吸内科系

    杉浦久敏

  3. 阿斯利康，威尔明顿，DE，美国

    帕特里克·达肯

  4. 阿斯利康，达勒姆，北卡罗来纳州，美国

    保罗·多林斯基

作者
  1. Shigeo Muro查看作者出版物

    您也可以在PubMed Google Scholar中搜索此作者 

  2. Hisatoshi Sugiura查看作者出版物

    您也可以在PubMed Google Scholar中搜索此作者 

  3. Patrick Darken查看作者出版物

    您也可以在PubMed Google Scholar中搜索此作者 

  4. Paul Dorinsky查看作者出版物

    您也可以在PubMed Google Scholar中搜索此作者 

通讯作者

致室友茂夫的信件。

出版商说明

Springer Nature 对已出版地图和机构附属机构中的管辖权主张保持中立。

开放获取本文根据知识共享署名 4.0 国际许可协议获得许可，该许可允许以任何媒体或格式使用、共享、改编、分发和复制，只要您适当注明原作者和来源，提供链接到知识共享许可，并指出是否进行了更改。本文中的图像或其他第三方材料包含在文章的知识共享许可中，除非在材料的信用额度中另有说明。如果文章的知识共享许可中未包含材料，并且您的预期用途未得到法律法规的允许或超出允许的用途，则您需要直接从版权所有者处获得许可。要查看此许可证的副本，请访问 http://creativecommons.org/licenses/by/4.0/。

重印和许可

通过 CrossMark 验证货币和真实性

引用这篇文章

Muro, S.、Sugiura, H.、Darken, P.等。更正：布地奈德/格隆铵/福莫特罗计量吸入器对 COPD 患者的疗效：来自 KRONOS 研究的事后分析，排除了气道可逆性和嗜酸性粒细胞计数高的患者。Respir Res 22, 223 (2021)。https://doi.org/10.1186/s12931-021-01803-y

下载引文

  • 发表：

  • DOI : https://doi.org/10.1186/s12931-021-01803-y
更新日期：2021-08-09
  点击分享   查看原文
点击收藏
公开下载
阅读更多本刊最新论文 本刊介绍/投稿指南11
down
wechat
bug